Mechanisms of dyslipoproteinemias in systemic lupus erythematosus

被引：64

作者：

Borba, Eduardo F. ^{[1
]}

Carvalho, Jozelio F. ^{[1
]}

Bonfa, Eloisa ^{[1
]}

机构：

[1] Sao Paulo Univ Hosp, Div Rheumatol, Sch Med, Sao Paulo, Brazil

来源：

CLINICAL & DEVELOPMENTAL IMMUNOLOGY | 2006年 / 13卷 / 2-4期

关键词：

systemic lupus erythematosus; lipoprotein; dyslipoproteinemia; hyperlipidemia; atherosclerosis; inflammation;

D O I：

10.1080/17402520600876945

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Autoimmunity and inflammation are associated with marked changes in lipid and lipoprotein metabolism in SLE. .Autoantibodies and cytokines are able to modulate lipoprotein lipase (LPL) activity, a key enzyme in lipid metabolism, with a consequent "lupus pattern" of dyslipoproteinemia characterized by elevated levels of very low-density lipoprotein cholesterol (VLDL) and triglycerides (TG) and lower high-density lipoprotein cholesterol (HDL) levels. This pattern favors an enhanced LDL oxidation with a subsequent deleterious foam cell formation. Autoantibodies and immunocomplexes may aggravate this oxidative injury by inducing accumulation and deposition of oxLDL in endothelial cells. Drugs and associated diseases usually magnify the close interaction of these factors and further promote the proatherogenic environment of this disease.

引用

页码：203 / 208

页数：6

共 102 条

[91]

SPRONK PE, 1992, CLIN EXP IMMUNOL, V90, P106

[92]

STENDER S, 1981, ARTERIOSCLEROSIS, V1, P28

[93] Elevated triglycerides and low levels of high-density lipoprotein as markers of disease activity in association with up-regulation of the tumor necrosis factor α/tumor necrosis factor receptor system in systemic lupus erythematosus [J].

Svenungsson, E ;

Gunnarsson, I ;

Fei, GZ ;

Lundberg, IE ;

Klareskog, L ;

Frostegård, J .

ARTHRITIS AND RHEUMATISM, 2003, 48 (09) :2533-2540

[94] TNF-α:: a link between hypertriglyceridaemia and inflammation in SLE patients with cardiovascular disease [J].

Svenungsson, E ;

Fei, GZ ;

Jensen-Urstad, K ;

de Faire, U ;

Hamsten, A ;

Frostegård, J .

LUPUS, 2003, 12 (06) :454-461

[95] Risk factors for cardiovascular disease in systemic lupus erythematosus [J].

Svenungsson, E ;

Jensen-Urstad, K ;

Heimbürger, M ;

Silveira, A ;

Hamsten, A ;

de Faire, U ;

Witztum, JL ;

Frostegård, J .

CIRCULATION, 2001, 104 (16) :1887-1893

[96] The metabolic syndrome is associated with elevated circulating C-reactive protein in healthy reference range, a systemic low-grade inflammatory state [J].

Tamakoshi, K ;

Yatsuya, H ;

Kondo, T ;

Hori, Y ;

Ishikawa, M ;

Zhang, H ;

Murata, C ;

Otsuka, R ;

Zhu, S ;

Toyoshima, H .

INTERNATIONAL JOURNAL OF OBESITY, 2003, 27 (04) :443-449

[97]

TANAKA Y, 1988, J IMMUNOL, V141, P3043

[98] DEFECTS OF RECEPTOR-MEDIATED LOW-DENSITY LIPOPROTEIN CATABOLISM IN HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA AND HYPOTHYROIDISM INVIVO [J].

THOMPSON, GR ;

SOUTAR, AK ;

SPENGEL, FA ;

JADHAV, A ;

GAVIGAN, SJP ;

MYANT, NB .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1981, 78 (04) :2591-2595

[99] CROSS-REACTION BETWEEN ANTIBODIES TO OXIDIZED LOW-DENSITY-LIPOPROTEIN AND TO CARDIOLIPIN IN SYSTEMIC LUPUS-ERYTHEMATOSUS [J].

VAARALA, O ;

ALFTHAN, G ;

JAUHIAINEN, M ;

LEIRISALOREPO, M ;

AHO, K ;

PALOSUO, T .

LANCET, 1993, 341 (8850) :923-925

[100] Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response - Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures [J].

VanLenten, BJ ;

Hama, SY ;

deBeer, FC ;

Stafforini, DM ;

McIntyre, TM ;

Prescott, SM ;

LaDu, BN ;

Fogelman, AM ;

Navab, M .

JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (06) :2758-2767

← 2 3 4 5 6 7 8 9 10 11 →